Trials / Sponsors / Shanghai Juncell Therapeutics
Shanghai Juncell Therapeutics
Industry · 18 registered clinical trials — 15 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | A Study of TIL in Advanced Solid Tumors (CZ) Solid Tumor, Adult | Phase 1 | 2026-05-08 |
| Not Yet Recruiting | A Study of GC203 TIL in Advanced Solid Tumors (NF) Solid Tumors, Adult | Phase 1 | 2026-01-30 |
| Recruiting | A Study of GC203 TIL in PDCA (RJ) Pancreatic Cancer, Pancratic Ductal Adenocarcinoma, Treatment Side Effects | EARLY_Phase 1 | 2025-02-10 |
| Recruiting | A Study of GC101 TIL in Advanced Melanoma Melanoma | Phase 2 | 2024-12-20 |
| Recruiting | A Phase Ib Study of GC101 in NSCLC Non Small Cell Lung Cancer Metastatic, Non Small Cell Lung Cancer | Phase 1 | 2024-10-14 |
| Recruiting | A Study of GC203 TIL in Advanced Malignant Solid Tumors Solid Tumor, Gynecologic Cancer, Breast Cancer | Phase 1 | 2024-05-29 |
| Completed | A Study of GC101 TIL in Advanced Melanoma (BZ) Tumor Infiltrating Lymphocytes, Safety, Melanoma | Phase 1 / Phase 2 | 2023-11-08 |
| Recruiting | A Study of TIL in Advanced Solid Tumors (DFGD) Advanced Solid Tumor, Tumor Infiltrating Lymphocytes, Treatment Side Effects | EARLY_Phase 1 | 2023-04-01 |
| Completed | A Phase I Study of GC101 TIL in Advanced Solid Tumors Tumor Infiltrating Lymphocytes, Safety, Advanced Solid Tumor | Phase 1 | 2022-10-12 |
| Completed | A Study of GC203 TIL in Advanced Gynecologic Tumors (10hospital) Advanced Gynecologic Tumors, TIL Engineered With Membrane-Binding Cytokine, Treatment Side Effects | EARLY_Phase 1 | 2022-03-10 |
| Recruiting | A Clinical Study on TIL for the Treatment of Advanced Solid Tumors Advanced Solid Tumor, Tumor Infiltrating Lymphocytes, Treatment Side Effects | EARLY_Phase 1 | 2021-12-10 |
| Recruiting | A Study of GC101 TIL in Advanced Breast Cancer (10hospital) Breast Cancer, Treatment Side Effects, Advanced Breast Cancer | EARLY_Phase 1 | 2021-11-19 |
| Recruiting | A Study of GC201 TIL in Advanced Gynecologic Tumors (10hospital) Advanced Gynecologic Tumors, Signal Switch Receptor Modified TIL, Treatment Side Effects | EARLY_Phase 1 | 2021-09-26 |
| Recruiting | A Study of GC101 TIL in Advanced Melanoma (10hospital) Advanced Melanoma, Tumor Infiltrating Lymphocyte, Treatment Side Effects | EARLY_Phase 1 | 2021-09-26 |
| Recruiting | A Study of GC101 TIL in Advanced Hepatobiliary-Pancreatic Cancers (10hospital) Advanced Liver Cancers, Tumor Infiltrating Lymphocyte, Treatment Side Effects | EARLY_Phase 1 | 2021-09-26 |
| Recruiting | A Study of GC101 TIL in r/r Gastrointestinal Tumors (10hospital) Gastrointestinal Tumor | EARLY_Phase 1 | 2021-06-30 |
| Recruiting | Study of GC101 TIL in Brain Glioma (Soochow2) Glioma | EARLY_Phase 1 | 2021-05-06 |
| Recruiting | A Study of GC101 TIL in Advanced Solid Tumors (TR) Advanced Solid Tumors | EARLY_Phase 1 | 2021-04-22 |